GLP-1 receptor agonists in the treatment of T2DM

At least six oral and two injectable medication classes are available as therapeutic options in Australia
Dr Mahesh Umapathysivam Dr Chinmay Marathe

According to Australian Institute of Health and Welfare data from 2017-18, approximately 5% of Australians have diabetes, and the condition accounts for 1.2 million hospitalisations annually.1

More than 90% of those with diabetes have type 2 diabetes. At least six oral and two injectable medication classes are available as therapeutic options in Australia (see box 1).2